E. De Waele
Vrije Universiteit Brussel
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E. De Waele.
Blood Purification | 2011
Rita Jacobs; Patrick M. Honore; Olivier Joannes-Boyau; Willem Boer; J. De Regt; E. De Waele; Vincent Collin; Herbert D. Spapen
For a long time, acute kidney injury (AKI) was considered to be a primarily hemodynamic condition characterized by a reduction of renal blood flow, induced by either cardiogenic or distributive (septic) shock. Consequently, all efforts to treat AKI were essentially concentrated on increasing renal flow by enhancing cardiac flow output and perfusion pressure. At the beginning of this decade, Bellomo and co-workers produced new and intriguing data in an animal model of septic AKI that undermined existing concepts. They observed that medullar and cortical renal blood flow were both maintained and even increased in septic shock, underscoring that septic AKI was a totally different physiological phenomenon than nonseptic AKI. Also, apoptosis was found to play a more important role in sepsis and septic shock than pure necrosis. Despite these findings, the role of apoptosis as a main mechanism of organ dysfunction remains topic of debate.
Blood Purification | 2012
Patrick M. Honore; Rita Jacobs; Willem Boer; Olivier Joannes-Boyau; J. De Regt; E. De Waele; V. Van Gorp; Vincent Collin; Herbert D. Spapen
Mediator removal from tissue (capillary blood compartment, CABC) and transport to the central circulation (central blood compartment, CEBC) must be effective. Effectiveness through a passive mechanism seems unlikely as the surface of CEBC (30 m2) is smaller than CABC (300 m2) whereby the former will be a limiting factor in passive transport. According to studies, a high exchange volume can induce an 80-fold increase in lymphatic flow. This results in displacement (active transport) of mediators to CEBC. Recent studies have shown that the delivered dose constitutes the mainstay of continuous renal replacement therapy. However, these results are not likely to change the recommendation: 35 ml/kg/h, adjusted for predilution, in septic acute kidney injury (AKI). Recently, studies were focusing on global intensive care unit AKI. In non-septic AKI, those studies show that 20–25 ml/kg/h was optimal. The DO-RE-MI trial underscored the importance of delivery which could be obtained by targeting doses between 5 and 10 ml/kg/h higher than prescribed. Until the IVOIRE trial becomes available, septic AKI should be treated by continuous veno-venous hemofiltration at 35 ml/kg/h. In non-septic AKI, 25 ml/kg/h remains optimal.
Acta Anaesthesiologica Scandinavica | 2015
E. De Waele; K. van Zwam; S. Mattens; K. Staessens; Marc Diltoer; Patrick M. Honore; Jens Czapla; Jan Nijs; M. La Meir; L. Huyghens; Herbert D. Spapen
Extracorporeal membrane oxygenation (ECMO) is increasingly used in patients with severe respiratory failure. Indirect calorimetry (IC) is a safe and non‐invasive method for measuring resting energy expenditure (REE). No data exist on the use of IC in ECMO‐treated patients as oxygen uptake and carbon dioxide elimination are divided between mechanical ventilation and the artificial lung. We report our preliminary clinical experience with a theoretical model that derives REE from IC measurements obtained separately on the ventilator and on the artificial lung.
International Journal of Nephrology and Renovascular Disease | 2014
R Kishen; Patrick M. Honore; Rita Jacobs; Olivier Joannes-Boyau; E. De Waele; J. De Regt; V. Van Gorp; Willem Boer; Herbert D. Spapen
Acid–base disorders are common in the critically ill. Most of these disorders do not cause harm and are self-limiting after appropriate resuscitation and management. Unfortunately, clinicians tend to think about an acid–base disturbance as a “disease” and spend long hours effectively treating numbers rather than the patient. Moreover, a sizable number of intensive-care physicians experience difficulties in interpreting the significance of or understanding the etiology of certain forms of acid–base disequilibria. Traditional tools for interpreting acid–base disorders may not be adequate for analyzing the complex nature of these metabolic abnormalities. Inappropriate interpretation may also lead to wrong clinical conclusions and incorrectly influence clinical management (eg, bicarbonate therapy for metabolic acidosis in different clinical situations). The Stewart approach, based on physicochemical principles, is a robust physiological concept that can facilitate the interpretation and analysis of simple, mixed, and complex acid–base disorders, thereby allowing better diagnosis of the cause of the disturbance and more timely treatment. However, as the concept does not attach importance to plasma bicarbonate, clinicians may find it complicated to use in their daily clinical practice. This article reviews various approaches to interpreting acid–base disorders and suggests the integration of base-excess and Stewart approach for a better interpretation of these metabolic disorders.
International Journal of Nephrology and Renovascular Disease | 2013
Stijn Lochy; Rita Jacobs; Pm Honoré; E. De Waele; Olivier Joannes-Boyau; J. De Regt; V. Van Gorp; Herbert D. Spapen
Acute phosphate nephropathy or nephrocalcinosis is a tubulointerstitial nephropathy characterized by tubular calcium phosphate deposition – crystal nephropathy – and slowly progressive renal insufficiency during or following treatment with preparations containing sodium phosphate. We report a patient who developed nephrocalcinosis (crystal induced acute kidney injury) following the administration of a combination of oral and rectal sodium phosphate for treatment of postoperative constipation. A timely renal replacement therapy procedure may reverse the process of crystallization and the irreversible slope towards chronic dialysis.
Diabetologia | 2010
Daisy Flamez; Isabelle Roland; Alix Berton; Burak Kutlu; Denis Dufrane; Marie-Claire Beckers; E. De Waele; Ilse Rooman; Luc Bouwens; Anna Clark; M Lonneux; J F Jamar; Serge Goldman; Didier Marechal; Nathan Goodman; Pierre Gianello; C Van Huffel; Isabelle Salmon; Decio L. Eizirik
Clinical Nutrition | 2017
E. De Waele; K. Staessens; J. Demol; M. La Meir; H.D. Sapen
Critical Care | 2014
E. De Waele; K. De Bondt; J Czapla; J Nijs; Duc Nam Nguyen; Pm Honoré; Herbert D. Spapen
Archive | 2018
E. De Waele; Patrick M. Honore; M.L. Malbrain
Clinical Nutrition | 2018
J. Demol; E. De Waele; Herbert D. Spapen; M.L. Malbrain; J. De Grève; Joeri J. Pen; C. Riccardo; P. Cotogni